Endocrine Oncology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Endocrine oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Endocrine Oncology Today - Breaking & Trending Today

Enterome to Present Data on EO2401 in Adrenal Tumors at the European Society for Medical Oncology (ESMO) 2023 Congress

Oral Presentation at ESMO will feature updated results from Phase 1/2 SPENCER studyPARIS, Oct. 16, 2023 (GLOBE NEWSWIRE) Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liquid malignancies and inflammatory diseases based on its unique Mimicry platform, today announced that updated data from its Phase 1/2 SPENCER study on EO2401, in combination with nivolumab in patients with adrenal tumors, will be presented in an oral session at the European ....

France General , Guillaume Bayre , Weid Europe , Gustave Roussy Villejuif , Eric Baudin , Ashleyr Robinson , Lifesci Advisors , European Society For Medical Oncology , Health Science , Head Of External Communications , Oral Presentation , European Society , Medical Oncology , Associate Professor , Endocrine Oncology Unit , Gustave Roussy , Paper Session , Tumor Associated Antigens , Universal Cancer Peptide , Adrenal Tumors , Immunomodulatory Drugs , Inflammatory Diseases , Phase 2 Clinical Trial , Oral Presentation , Gustave Roussy , Endocrine Oncology ,

Triple Therapy Boosts Anaplastic Thyroid Cancer Survival

With the neoadjuvant regimen of pembrolizumab added to dabrafenib and trametinib, survival in BRAF-mutated forms of the highly aggressive cancer can go from months to more than 5 years. ....

United States , Sarah Hamidi , Mariae Cabanillas , Sarimar Agosto Salgado , H Lee Moffitt Cancer Center , Department Of Head , Research Institute , Department Of Endocrine Neoplasia , Md Anderson Cancer Center , American Thyroid Association , University Of Texas Md Anderson Cancer Center , Drug Administration , Endocrine Neoplasia , Hormonal Disorders , Cancer Center , Medscape Medical , Endocrine Oncology , Moffitt Cancer Center , Thyroid Cancer , Thyroid Carcinoma , Ancer Of The Thyroid , Malignant Head And Neck Neoplasm , Thyroid Disorder , Anaplastic Thyroid Carcinoma , Naplastic Carcinoma Of The Thyroid , Nt Ears ,

Is Oral Sex Really a Leading Risk Factor for Throat Cancer?

An op-ed, published in April in The Conversation, pointed to oral sex as the leading risk factor for throat cancer. The leading risk factor for all throat cancer in most developed countries is human papillomavirus (HPV), which can be transmitted via oral sex. ....

United States , Electra Paskett , Matin Imanguli , Neil Gross , George Yang , Hisham Mehanna , Centers For Disease , Md Anderson Cancer Center , Ohio State University Wexner Medical Center , Institute Of Cancer , Department Of Head , University Of Birmingham , Rutgers Cancer Institute Of New Jersey , Genomic Sciences , Endocrine Oncology At Moffitt Cancer Center , Oral Sex Really , Leading Risk Factor , Neck Surgery , Cancer Center , Disease Control , Rutgers Cancer Institute , New Jersey , Endocrine Oncology , Moffitt Cancer Center , Can You Reduce Your Risk ,

Investegate |ITM Isotope Technologies Munic Announcements | ITM Isotope Technologies Munic: ITM to Present Phase III COMPOSE Poster and Host Satellite Symposium on Radiotheranostics in NET cancer at ENETS Conference

Investegate announcements from ITM Isotope Technologies Munic, ITM to Present Phase III COMPOSE Poster and Host Satellite Symposium on Radiotheranostics in NET cancer at ENETS Conference ....

United States , Uppsala Lan , Comunidad Autonoma De Cataluna , Jaume Capdevila , Ben Orzelek , Julia Hofmann Svenja , Wolfgang Weber , Aldo Scarpa , Heloisa Soares , Uppsala University , Hospital Trust Of Verona , Hebron University Hospital , University Of Utah , European Neuroendocrine Tumor Society , Technical University Of Munich , Corporate Communications , Department Of Pathology , Oncology Department , Symposium Program , Department Of Nuclear Medicine , Division Of Oncology , Present Phase , Host Satellite Symposium , Annual European Neuroendocrine Tumor Society , Therapeutics Landscape , Medical Oncology Department ,

ITM to Present Phase III COMPOSE Poster and Host Satellite

Garching / Munich, March 16, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical theranostics company, today announced that the. ....

United States , Uppsala Lan , Comunidad Autonoma De Cataluna , Jaume Capdevila , Ben Orzelek , Julia Hofmann Svenja , Wolfgang Weber , Aldo Scarpa , Heloisa Soares , Uppsala University , Hospital Trust Of Verona , Hebron University Hospital , University Of Utah , European Neuroendocrine Tumor Society , Technical University Of Munich , Corporate Communications , Department Of Pathology , Oncology Department , Symposium Program , Department Of Nuclear Medicine , Division Of Oncology , Annual European Neuroendocrine Tumor Society , Therapeutics Landscape , Medical Oncology Department , Endocrine Tumor Unit , Endocrine Oncology ,